Jefferies analyst, Jeffrey Holford, reiterated his Underperform rating on shares of Merck (NYSE: MRK) after the company submitted a surprise ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE